SGK3 and depressive symptom measurement: According to Spearman correlation, the correlation between PI3K/Akt/mTOR pathway and gut microbiota or metabolites can explain how SGKL treatment affects the PI3K/Akt/mTOR pathway activity in the hippocampus during depression progression.